Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma.
about
Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer.Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway.Clinical impact of serum soluble SLAMF7 in multiple myelomaSoluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia
P2860
Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Soluble PD-L1: A biomarker to ...... atients with multiple myeloma.
@en
Soluble PD-L1: A biomarker to ...... atients with multiple myeloma.
@nl
type
label
Soluble PD-L1: A biomarker to ...... atients with multiple myeloma.
@en
Soluble PD-L1: A biomarker to ...... atients with multiple myeloma.
@nl
prefLabel
Soluble PD-L1: A biomarker to ...... atients with multiple myeloma.
@en
Soluble PD-L1: A biomarker to ...... atients with multiple myeloma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Soluble PD-L1: A biomarker to ...... patients with multiple myeloma
@en
P2093
Chi-Cheng Li
Chung-Wu Lin
Hsiu-Hsia Lin
P2860
P304
62490-62502
P356
10.18632/ONCOTARGET.11519
P407
P577
2016-09-01T00:00:00Z